Abstract
Helicobacter pylori infection is considered an important health problem due to the fact that there are reports that describe that more than 50% of the world's populations is affected by it. The infection has been associated with multiple diseases, gastric and extra-gastric, whose signs and symptoms are overlooked most of the time. Nowadays diagnostic methods have evolved in such a way that they are available for most of the population. Among the treatment schemes is the triple therapy, which is the most effective because it reaches 90% levels of microorganism eradication. For that reason we considered it of great importance doing a review of the most relevant things in literature about this bacteria and the diseases it is associated.
MeSH terms
-
Adult
-
Anti-Bacterial Agents
-
Anti-Ulcer Agents / administration & dosage
-
Anti-Ulcer Agents / therapeutic use
-
Antibodies, Bacterial / blood
-
Autoimmune Diseases / etiology
-
Autoimmune Diseases / immunology
-
Breath Tests
-
Carcinoma / etiology
-
Cardiovascular Diseases / etiology
-
Child
-
Child, Preschool
-
Cytokines / blood
-
Drug Therapy, Combination / administration & dosage
-
Drug Therapy, Combination / therapeutic use
-
Gastritis / etiology
-
Helicobacter Infections / complications*
-
Helicobacter Infections / diagnosis
-
Helicobacter Infections / drug therapy
-
Helicobacter Infections / epidemiology
-
Helicobacter Infections / immunology
-
Helicobacter pylori / immunology
-
Helicobacter pylori / pathogenicity*
-
Helicobacter pylori / physiology
-
Humans
-
Skin Diseases / epidemiology
-
Skin Diseases / etiology
-
Skin Diseases / immunology
-
Stomach Neoplasms / etiology
Substances
-
Anti-Bacterial Agents
-
Anti-Ulcer Agents
-
Antibodies, Bacterial
-
Cytokines